
Health Care Technology
Verana Health Announces Launch Of Qdata® Uveitic Macular Edema Module
By GlobeNewswire

Expansive, high-quality real-world dataset of more than 152,000 de-identified patients utilizes electronic health record data to confirm the diagnosis and better understand the outcomes of patients with uveitic macular edema.
SAN FRANCISCO, May 30, 2024 (GLOBE NEWSWIRE) -- Verana Health®, a digital health company dedicated to revolutionizing patient care and clinical research through real-world data (RWD), today announced the launch of its Qdata® Uveitic Macular Edema (UME) module, a dataset containing curated variables such as visual acuity (VA), central subfield thickness (CST) and intraocular pressure (IOP).
This latest Qdata module, which includes an average of nearly four years of follow-up data on more than 152,000 de-identified patients, represents a major advancement in the management and treatment of UME, a prevalent complication of uveitis that leads to significant visual loss. The module integrates exclusive structured and unstructured electronic health record (EHR) data from the American Academy of Ophthalmology IRIS® Registry (Intelligent Research in Sight), offering critical insights into diagnosis accuracy, patient journey specifics, and treatment efficacy. The dataset can support clinical development, health economics and outcomes research, and medical affairs teams by accelerating therapy development, monitoring real-world treatment patterns and outcomes, and informing site selection and patient identification.
"While there are effective steroid treatments for UME, it often requires regular injections to prevent the disease from progressing to the point of vision loss. This highlights a real need to understand the best treatment plan based on patient characteristics and demographics,” said Sujay Jadhav, CEO of Verana Health. "Our Qdata UME module addresses a significant gap in UME research and treatment by going beyond standard diagnostic codes and identifying key variables that can be extracted from clinician notes within EHRs to help evaluate the efficacy of treatments.”
This newly launched dataset follows Verana Health’s recent announcement of the development of Qdata Dry Eye Disease and the launch of Qdata Thyroid Eye Disease – further adding to the company’s ophthalmology research capabilities. To learn more about Verana Health’s Ophthalmology Qdata, click here.
About Verana Health
Verana Health® is revolutionizing patient care and clinical research by unlocking the potential of real-world data. Verana Health has an exclusive real-world data network of 90 million de-identified patients from more than 20,000 clinicians, stemming from its exclusive data partnerships with leading medical societies. Verana Health harnesses deep expertise, secure advanced technology, and direct access to exclusive, near real-time data sources to deliver actionable quality insights that help companies make sense of the data. For more information, visit www.veranahealth.com.
Media Contact:
MikeWorldWide
847.224.6462
veranahealth@mww.com
First published on Thu, May 30, 2024
Enjoyed what you've read so far? Great news - there's more to explore!
Stay up to date with the latest news, a vast collection of tech articles including introductory guides, product reviews, trends and more, thought-provoking interviews, hottest AI blogs and entertaining tech memes.
Plus, get access to branded insights such as informative white papers, intriguing case studies, in-depth reports, enlightening videos and exciting events and webinars from industry-leading global brands.
Dive into TechDogs' treasure trove today and Know Your World of technology!
Disclaimer - Reference to any specific product, software or entity does not constitute an endorsement or recommendation by TechDogs nor should any data or content published be relied upon. The views expressed by TechDogs' members and guests are their own and their appearance on our site does not imply an endorsement of them or any entity they represent. Views and opinions expressed by TechDogs' Authors are those of the Authors and do not necessarily reflect the view of TechDogs or any of its officials. While we aim to provide valuable and helpful information, some content on TechDogs' site may not have been thoroughly reviewed for every detail or aspect. We encourage users to verify any information independently where necessary.
Trending GlobeNewswire
Bexback Launches 100X Leverage, No KYC, $50 Welcome Bonus, And Double Deposit Bonus To Empower Crypto Futures Traders
By GlobeNewswire
Bitcoin Solaris To Launch Developer API Suite For Seamless Blockchain App Migration And Deployment
By GlobeNewswire
Doge Jones Industrial Average Partners With Indexify To Launch First Functional Memecoin Index
By GlobeNewswire
New One-Click Mining Function Launched, XRP, BTC And DOGE Users Can Easily Mine
By GlobeNewswire
Nimanode Launches First AI Agent Platform On XRP Ledger, Powered By NMA Token Launch
By GlobeNewswire
Join Our Newsletter
Get weekly news, engaging articles, and career tips-all free!
By subscribing to our newsletter, you're cool with our terms and conditions and agree to our Privacy Policy.
Join The Discussion